Related Experiment Video
Updated: Feb 4, 2026

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds
Published on: June 6, 2015
Update in non-invasive prenatal testing.
Valentina D'ambrosio1, Antonia Squarcella2,3, Flaminia Vena1
1Department of Gynecological, Obstetrical, and Urological Sciences, Sapienza University, Rome, Italy.
Non-invasive prenatal testing (NIPT) offers superior screening for common aneuploidies like trisomy 21. Advances in genomic technology expand NIPT to sub-chromosomal aneuploidies, but require further clinical validation.
Area of Science:
- Genetics
- Reproductive Medicine
- Genomic Technologies
Background:
- Non-invasive prenatal testing (NIPT) has become the leading screening method for common autosomal aneuploidies, significantly impacting prenatal diagnosis.
- Emerging genomic technologies, particularly next-generation sequencing, are expanding NIPT's scope to include sub-chromosomal aneuploidies.
- Existing diagnostic tests carry miscarriage risks, whereas NIPT offers a safer alternative with higher diagnostic yield.
Purpose of the Study:
- To review the advancements and current status of non-invasive prenatal testing (NIPT).
- To discuss the expansion of NIPT to sub-chromosomal aneuploidies using genomic technologies.
- To highlight the need for further clinical validation of these expanded NIPT applications.
Main Methods:
- Review of scientific literature on non-invasive prenatal testing.
- Analysis of the impact of next-generation sequencing on prenatal screening.
- Discussion of recommendations from scientific societies regarding NIPT implementation.
Main Results:
- NIPT is the most effective screening method for common autosomal aneuploidies, including trisomy 21.
- Genomic technologies have enabled NIPT to screen for sub-chromosomal aneuploidies.
- NIPT provides a higher diagnostic yield without the miscarriage risk associated with invasive diagnostic tests.
Conclusions:
- NIPT represents a significant revolution in prenatal diagnosis, offering superior screening for common aneuploidies.
- The expansion of NIPT to sub-chromosomal aneuploidies necessitates further clinical validation to understand its full potential and limitations.
- Guidelines from scientific societies address the appropriate use of cell-free DNA screening in pregnancy, reflecting the transformative impact of NIPT.
Related Concept Videos
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Significance Testing: Overview
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
Testing Water Quality
Types of Hypothesis Testing
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...

